QR678

QR678 is a **patented hair growth formulation** consisting of a **combination of growth factors and peptides** designed to treat various forms of alopecia. The formulation contains **vascular endothelial growth factor (VEGF)**, **basic fibroblast growth factor (bFGF)**, **insulin-like growth factor-1 (IGF-1)**, **keratinocyte growth factor (KGF)**, and **copper tripeptide-1**, along with supporting nutrients including vitamins, minerals, and amino acids. The mechanism of action works by delivering these growth factor proteins directly into the scalp through intradermal injections, targeting hair follicles to help them revive, regenerate, and strengthen. The treatment stimulates natural hair growth by **prolonging the anagen (growth) phase** of the hair cycle, improving the scalp's microenvironment, enhancing blood circulation, and ensuring better nutrition for follicles. QR678 was developed in India and has received **US and Indian patent protection** as well as **Indian FDA approval** for commercial use. Clinical studies have demonstrated that QR678 shows approximately **80% better results compared to PRP (Platelet Rich Plasma) therapy** for androgenetic alopecia. The formulation is administered through a series of **8 sessions at 3-4 weekly intervals**. Primary indications include **male pattern baldness**, **female pattern baldness**, **androgenetic alopecia**, **alopecia areata**, **chemotherapy-induced alopecia**, and **hair thinning**.

Brand names

QR678QR-678QR 678

Other names

QR 678QR678QR-678